[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"chain-detail":3,"chain-related-deccf963-6b65-4294-9291-483b47327169":770,"chain-scenarios-deccf963-6b65-4294-9291-483b47327169":778,"chain-expert-resolve-deccf963-6b65-4294-9291-483b47327169":780},{"id":4,"name":5,"category":6,"groupCategory":7,"intro":8,"scale":9,"maturity":10,"meta":11,"checkState":461,"version":462,"createdBy":96,"createdAt":463,"updatedAt":464,"nodes":465},"deccf963-6b65-4294-9291-483b47327169","基因与生物技术产业链","未来产业","FUTURE","基因编辑、合成生物学、生物制造","中国基因组测序市场规模约328.6亿元(灼识咨询\u002F中国医疗器械行业协会基因检测分会白皮书,2025);中国细胞与基因治疗(CGT)市场规模2025年首次突破500亿元(行业公开统计,2025)","孕育期",{"ipc":12,"trl":22,"tier":25,"codes":26,"trade":28,"counts":36,"market":40,"source":60,"experts":61,"shaanxi":96,"sources":97,"clusters":102,"maturity":10,"policies":175,"source60":190,"chainCode":27,"matched60":191,"bottlenecks":192,"competition":383,"subCategory":389,"lifecycleStage":390,"strategic_note":391,"strategic_path":392,"key_technologies":396,"national_policies":406,"value_chain_profile":411,"regional_distribution":427},[13,16,19],{"code":14,"meaning":15},"C12Q 1\u002F68","核酸测定(基因测序\u002F分子检测)",{"code":17,"meaning":18},"G01N 33\u002F53","免疫测定(重组蛋白\u002F抗体试剂)",{"code":20,"meaning":21},"C12N 15\u002F00","DNA重组\u002F基因工程",{"basis":23,"range":24},"基因测序仪、PCR\u002F分子诊断试剂、模式动物、生物信息软件已规模商用(TRL8-9);体内基因治疗、碱基编辑、合成生物设计工具处临床\u002F工程验证(TRL5-7)","TRL6-9","战略性新兴产业",[27],"F03",{"exports":29,"sources":30,"dependence":32,"export_yoy":33,"export_label":34,"export_value":33,"imports_note":35},"中国生物技术上游以进口为主，高端仪器\u002F试剂长期逆差；华大智造测序仪、部分试剂已实现出海",[31],"http:\u002F\u002Fpaper.cnstock.com\u002Fhtml\u002F2026-03\u002F28\u002Fcontent_2193628.htm","高端分析仪器进口率超80%，一次性塑料耗材国产化率仅约8.5%，为最突出卡脖子环节","","基因测序\u002F生物试剂出口","高端科研仪器、重组抗体、定制化蛋白、CRISPR工具酶、Protein A层析介质、高密度培养基大量依赖进口",{"clusters":37,"segments":38,"companies":39,"bottlenecks":38},4,9,16,{"china":41,"global":57},{"yoy":42,"breakdown":43,"size_2025":56},"测序约+18.7%(2025);CGT约+45%(2025)",[44,48,50,52],{"size":45,"share":46,"segment":47},"测序仪与耗材市场约占测序板块3-4成","待核实","基因测序仪与耗材",{"size":46,"share":46,"segment":49},"分子诊断\u002FPCR试剂",{"size":46,"share":46,"segment":51},"模式动物与实验动物",{"size":53,"share":54,"segment":55},"破500亿元(2025)","高增长","细胞与基因治疗(CGT)服务与平台","中国基因组测序市场约328.6亿元(白皮书\u002F灼识,2025);CGT市场破500亿元(2025)",{"note":58,"size_2025":59},"Illumina、华大智造、Thermo Fisher三家按收入合计市占约87%(华大智造2024年报);CGT领域全球由诺华\u002FKite(吉利德)\u002FBMS等主导","全球基因测序仪与耗材市场长期由Illumina\u002FThermo\u002FPacBio\u002FONT主导(华大智造年报口径)","全产业智慧图谱数据库（公开版）",[62,68,74,80,85,91],{"org":63,"raw":64,"name":65,"note":66,"title":67},"南方科技大学","朱健康（南方科技大学），美国科学院院士，植物基因编辑与精准育种方向","朱健康","植物基因编辑与精准育种方向","美国科学院院士",{"org":69,"raw":70,"name":71,"note":72,"title":73},"北京大学","邓宏魁（北京大学），教授，化学小分子诱导多能干细胞与基因编辑细胞治疗","邓宏魁","化学小分子诱导多能干细胞与基因编辑细胞治疗","教授",{"org":75,"raw":76,"name":77,"note":78,"title":79},"中国科学院动物研究所","王皓毅（中国科学院动物研究所），研究员，CRISPR等基因编辑技术研究","王皓毅","CRISPR等基因编辑技术研究","研究员",{"org":81,"raw":82,"name":83,"note":84,"title":79},"中国科学院遗传与发育生物学研究所","高彩霞（中国科学院遗传与发育生物学研究所），研究员，植物基因组编辑与育种应用","高彩霞","植物基因组编辑与育种应用",{"org":86,"raw":87,"name":88,"note":89,"title":90},"空军军医大学西京医院","窦科峰（空军军医大学西京医院），中国工程院院士，基因编辑猪器官异种移植研究与临床探索","窦科峰","基因编辑猪器官异种移植研究与临床探索","中国工程院院士",{"org":92,"raw":93,"name":94,"note":95,"title":73},"复旦大学附属眼耳鼻喉科医院","舒易来（复旦大学附属眼耳鼻喉科医院），教授，遗传性耳聋基因治疗临床试验牵头人","舒易来","遗传性耳聋基因治疗临床试验牵头人",null,[98,99,100,101],"http:\u002F\u002Fpaper.cnstock.com\u002Fhtml\u002F2025-04\u002F30\u002Fcontent_2062856.htm","http:\u002F\u002Fwww.cnstock.com\u002FcommonDetail\u002F688650","https:\u002F\u002Fwww.healthcarechn.com\u002Fh-nd-3397.html","https:\u002F\u002Fwww.gov.cn\u002Fyaowen\u002Fliebiao\u002F202512\u002Fcontent_7052337.htm",[103,107,111,114,117,120,123,126,129,132,135,138,141,144,147,150,153,156,158,161,164,166,169,172],{"city":104,"name":105,"level":106},"北京","中关村生命科学园","国家级",{"city":108,"name":109,"level":110},"上海","张江细胞与基因产业园","市级",{"city":112,"name":113,"level":96},"济南高新区","济南基因编辑产业基地",{"city":115,"name":116,"level":96},"Kendall Square","肯德尔广场",{"city":118,"name":119,"level":96},"BioBAY","苏州生物医药产业园",{"city":121,"name":122,"level":96},"黄埔科学城","广州开发区",{"city":124,"name":125,"level":96},"光谷生物城","武汉国家生物产业基地",{"city":127,"name":128,"level":96},"坪山","深圳国家生物产业基地",{"city":130,"name":131,"level":96},"江北新区","南京生物医药谷",{"city":133,"name":134,"level":106},"天津","天津滨海高新区“细胞谷”",{"city":136,"name":137,"level":96},"生命科技产业园","上海临港生命蓝湾",{"city":139,"name":140,"level":106},"成都","成都天府国际生物城",{"city":142,"name":143,"level":96},"泰州医药高新区","泰州中国医药城",{"city":145,"name":146,"level":96},"亦庄","北京经济技术开发区",{"city":148,"name":149,"level":96},"张江生物医药基地","张江药谷",{"city":151,"name":152,"level":110},"苏州","苏州太仓沙溪生物医药产业园",{"city":154,"name":155,"level":106},"合肥","合肥高新技术产业开发区",{"city":108,"name":157,"level":106},"张江科学城",{"city":159,"name":160,"level":96},"华大基因总部基地","深圳盐田",{"city":162,"name":163,"level":106},"广州","广州国际生物岛",{"city":139,"name":165,"level":106},"成都高新技术产业开发区",{"city":167,"name":168,"level":96},"南繁硅谷","三亚崖州湾科技城",{"city":170,"name":171,"level":106},"济南","济南高新技术产业开发区",{"city":173,"name":174,"level":106},"无锡","中国宜兴环保科技工业园",[176,183],{"url":177,"date":178,"name":179,"doc_no":180,"issuer":181,"summary":182},"https:\u002F\u002Fwww.gov.cn\u002Fzhengce\u002Fcontent\u002F2022-05\u002F10\u002Fcontent_5689576.htm","2022-05","《'十四五'生物经济发展规划》","发改高技〔2022〕686号","国家发展改革委","将生物技术、生物信息、基因与细胞治疗列为生物经济重点发展领域",{"url":184,"date":185,"name":186,"doc_no":187,"issuer":188,"summary":189},"https:\u002F\u002Fwww.gov.cn\u002Fzhengce\u002Fzhengceku\u002F202402\u002Fcontent_6929931.htm","2024-01","《关于推动未来产业创新发展的实施意见》","工信部联科〔2024〕12号","工业和信息化部等七部门","将合成生物、生物制造、基因与细胞治疗等列为未来产业","全产业60链图谱",true,[193,223,245,267,292,311,330,345,363],{"name":194,"risk":195,"type":96,"status":196,"experts":197,"policies":201,"progress":208,"companies":209,"policy_support":222},"高效低毒AAV\u002FLNP体内递送","风险：高","已突破",[198],{"org":92,"raw":199,"name":94,"note":200,"title":73},"舒易来（复旦大学附属眼耳鼻喉科医院），教授，遗传性耳聋基因治疗临床试验牵头人，涉及AAV内耳递送","遗传性耳聋基因治疗临床试验牵头人，涉及AAV内耳递送",[202],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},"《国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》（国务院办公厅，2025-01）：全面深化药品医疗器械审评审批与监管改革，支持创新药和高端医疗器械发展","2025-01","国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见","国务院办公厅","全面深化药品医疗器械审评审批与监管改革，支持创新药和高端医疗器械发展","信念医药、朗昇生物国产AAV推进",[210,213,216,219],{"name":211,"note":212},"派真生物","AAV载体",{"name":214,"note":215},"和元生物","病毒载体CDMO",{"name":217,"note":218},"深信生物","LNP递送技术",{"name":220,"note":221},"宜明细胞","载体CDMO","基因治疗",{"name":224,"risk":195,"type":225,"status":196,"experts":226,"policies":227,"progress":234,"companies":235,"policy_support":244},"通用型异体CAR-T量产工艺","工艺技术",[],[228],{"raw":229,"date":230,"name":231,"doc_no":96,"issuer":232,"summary":233},"《支持创新药高质量发展的若干措施》（国家医保局、国家卫生健康委，2025-07）：从研发、审评、医保支付、临床应用等全链条支持创新药发展","2025-07","支持创新药高质量发展的若干措施","国家医保局、国家卫生健康委","从研发、审评、医保支付、临床应用等全链条支持创新药发展","传奇、驯鹿医疗通用型CAR-T研发",[236,239,241],{"name":237,"note":238},"邦耀生物","通用型CAR-T",{"name":240,"note":238},"北恒生物",{"name":242,"note":243},"合源生物","CAR-T产业化","细胞治疗",{"name":246,"risk":195,"type":247,"status":196,"experts":248,"policies":249,"progress":256,"companies":257,"policy_support":266},"mRNA-LNP规模化生产","设备",[],[250],{"raw":251,"date":252,"name":253,"doc_no":96,"issuer":254,"summary":255},"《医药工业数智化转型实施方案（2025—2030年）》（工业和信息化部等部门，2025-04）：推动人工智能等数智技术在药物研发生产全链条的应用，加快医药工业转型升级","2025-04","医药工业数智化转型实施方案（2025—2030年）","工业和信息化部等部门","推动人工智能等数智技术在药物研发生产全链条的应用，加快医药工业转型升级","艾博、斯微生物mRNA疫苗临床",[258,260,262,264],{"name":259,"note":96},"艾博生物",{"name":261,"note":96},"斯微生物",{"name":217,"note":263},"LNP",{"name":265,"note":96},"瑞吉生物","mRNA药物",{"name":268,"risk":195,"type":225,"status":269,"experts":270,"policies":271,"progress":278,"companies":279,"policy_support":96},"高通量基因测序仪(NGS)与合成生物学","部分突破",[],[272],{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},"《中共中央关于制定国民经济和社会发展第十五个五年规划的建议》（中共中央，2025-10）：将生物制造等列为未来产业重点方向，提出加快高水平科技自立自强","2025-10","中共中央关于制定国民经济和社会发展第十五个五年规划的建议","中共中央","将生物制造等列为未来产业重点方向，提出加快高水平科技自立自强","国际标杆：Illumina NovaSeq(全球约70%份额)；中国华大智造已量产自研DNBSEQ测序仪并实现装机追赶，试剂耗材闭环，但超高端通量与生态仍有差距",[280,283,286,289],{"name":281,"note":282},"华大智造","高通量测序仪",{"name":284,"note":285},"齐碳科技","纳米孔测序仪",{"name":287,"note":288},"金斯瑞","基因合成",{"name":290,"note":291},"擎科生物","DNA合成",{"name":293,"risk":195,"type":225,"status":269,"experts":294,"policies":295,"progress":297,"companies":298,"policy_support":96},"高端科研仪器(质谱\u002F电镜\u002F流式)",[],[296],{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},"国际标杆：赛默飞、丹纳赫、蔡司、布鲁克；中国高端科学仪器整体进口率约70.6%，分析仪器进口率超80%，国仪量子\u002F聚光等在突破",[299,302,305,308],{"name":300,"note":301},"聚光科技","谱育科技质谱仪",{"name":303,"note":304},"禾信仪器","质谱仪",{"name":306,"note":307},"国仪量子","电子显微镜",{"name":309,"note":310},"迈瑞医疗","生命科学仪器",{"name":312,"risk":195,"type":225,"status":313,"experts":314,"policies":315,"progress":316,"companies":317,"policy_support":96},"重组抗体\u002F蛋白试剂与关键工具酶","依赖进口",[],[],"国际标杆：R&D Systems、Thermo；中国百普赛斯\u002F近岸蛋白在重组蛋白快速放量，但高端定制化蛋白进口依赖约53%、CRISPR工具酶进口依赖约69%",[318,321,324,327],{"name":319,"note":320},"义翘神州","重组蛋白与抗体试剂",{"name":322,"note":323},"百普赛斯","重组蛋白",{"name":325,"note":326},"近岸蛋白","mRNA原料酶及试剂",{"name":328,"note":329},"诺唯赞","生物酶原料",{"name":331,"risk":195,"type":225,"status":313,"experts":332,"policies":333,"progress":334,"companies":335,"policy_support":96},"细胞培养基与层析介质(上游卡脖子)",[],[],"国际标杆：Cytiva、Cytiva\u002F赛默飞；中国奥浦迈\u002F健顺生物培养基国产份额约15%(集中中低端)，高端Protein A介质进口依赖约68.5%",[336,339,342],{"name":337,"note":338},"奥浦迈","细胞培养基",{"name":340,"note":341},"纳微科技","色谱层析介质",{"name":343,"note":344},"澳斯康","培养基与CDMO",{"name":346,"risk":195,"type":225,"status":269,"experts":347,"policies":348,"progress":349,"companies":350,"policy_support":96},"一次性生物反应器\u002F耗材",[],[],"国际标杆：Cytiva、Sartorius；中国楚天科技\u002F森松国际在生物反应器装备突破，一次性塑料耗材国产化率仅约8.5%",[351,354,357,360],{"name":352,"note":353},"乐纯生物","一次性生物工艺耗材",{"name":355,"note":356},"多宁生物","生物工艺耗材",{"name":358,"note":359},"东富龙","制药装备与一次性系统",{"name":361,"note":362},"楚天科技","制药装备",{"name":364,"risk":195,"type":225,"status":313,"experts":365,"policies":371,"progress":374,"companies":375,"policy_support":96},"基因编辑(CRISPR)与基因治疗载体",[366,367,368],{"org":75,"raw":76,"name":77,"note":78,"title":79},{"org":81,"raw":82,"name":83,"note":84,"title":79},{"org":69,"raw":369,"name":71,"note":370,"title":73},"邓宏魁（北京大学），教授，基因编辑细胞治疗研究","基因编辑细胞治疗研究",[372,373],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},"国际标杆：Intellia、Editas；中国在基因治疗临床应用追赶，但AAV载体\u002F工具酶核心专利与上游试剂仍依赖进口",[376,378,380,382],{"name":377,"note":96},"博雅辑因",{"name":379,"note":96},"辉大基因",{"name":381,"note":96},"正序生物",{"name":211,"note":96},{"notes":384,"pattern":388},[385,386,387],"华大智造2025年营收27.8亿元,全读长测序仪全球新增销量超1470台","高端科研仪器(质谱\u002F电镜\u002F流式)仍高度依赖进口","模式动物(基因敲除小鼠)国产化率显著提升","基因测序仪环节华大智造为全球少数可与Illumina正面竞争的国产厂商;科研试剂\u002F高端仪器仍由Thermo Fisher\u002FDanaher\u002FAgilent等外资主导,国产替代空间大;CGTCDMO与工具平台国内企业快速崛起","未来健康（基因与生物技术）","GESTATION","本分片聚焦生命科学工具平台；重组蛋白\u002F抗体试剂、实验分析仪器、模式动物、CRO与测序服务多以部分活动(*)纳入生物产业，纯科研工具与工业生物制造边界在2018版中部分标*。",[393,394,395],"4 生物产业→4.1 生物医药产业→4.1.1 生物药品制品制造→生物药品制造(2761)、基因工程药物和疫苗制造(2762)","4 生物产业→4.1 生物医药产业→4.1.4 生物医药关键装备与原辅料制造→实验分析仪器(4014)","4 生物产业→4.5\u002F4.1.5 生物服务→医学研究和试验发展(7330)、工程和技术研究和试验发展(7320*)",[397,398,399,400,401,402,403,404,405],{"risk":195,"tech":194,"type":96,"status":196,"bottleneck":191,"domestic_status":208},{"risk":195,"tech":224,"type":225,"status":196,"bottleneck":191,"domestic_status":234},{"risk":195,"tech":246,"type":247,"status":196,"bottleneck":191,"domestic_status":256},{"risk":195,"tech":268,"type":225,"status":269,"bottleneck":191,"domestic_status":278},{"risk":195,"tech":293,"type":225,"status":269,"bottleneck":191,"domestic_status":297},{"risk":195,"tech":312,"type":225,"status":313,"bottleneck":191,"domestic_status":316},{"risk":195,"tech":331,"type":225,"status":313,"bottleneck":191,"domestic_status":334},{"risk":195,"tech":346,"type":225,"status":269,"bottleneck":191,"domestic_status":349},{"risk":195,"tech":364,"type":225,"status":313,"bottleneck":191,"domestic_status":374},[407,408,409,410],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},{"raw":251,"date":252,"name":253,"doc_no":96,"issuer":254,"summary":255},{"raw":229,"date":230,"name":231,"doc_no":96,"issuer":232,"summary":233},{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},{"note":412,"sources":413,"value_add":414},"生物技术价值链最厚利润在上游核心试剂\u002F仪器(类似‘卖水人’)，是国产替代的核心环节(券商研报综合)",[31],[415,419,423],{"share":416,"stage":417,"margin":418},"约40–45%","上游：科研仪器\u002F试剂\u002F耗材\u002F模式生物","高毛利50–70%，海外垄断",{"share":420,"stage":421,"margin":422},"约35–40%","中游：基因测序\u002FCDMO\u002FCRO工具平台","服务毛利30–50%",{"share":424,"stage":425,"margin":426},"约20–25%","下游：医疗诊断\u002F农业育种\u002F环保应用","应用端毛利25–40%",[428,433,438,441,445,449,453,457],{"scale":429,"layout":430,"region":431,"feature":432},"约426.8亿元，占全国约23%","上海、苏州、杭州","长三角(上海\u002F江浙)","生命科学试剂\u002F测序\u002FCRO最密集集群",{"scale":434,"layout":435,"region":436,"feature":437},"—","深圳、广州","粤港澳大湾区(广东)","基因测序\u002F合成生物\u002FIVD集群",{"scale":434,"layout":104,"region":439,"feature":440},"京津冀(北京)","国家级生命科学研究与模式生物",{"scale":434,"layout":442,"region":443,"feature":444},"武汉、长沙","华中(湖北\u002F湖南)","光谷生物城与生物制造",{"scale":434,"layout":446,"region":447,"feature":448},"成都、重庆","成渝(四川\u002F重庆)","生物医药与生物技术服务",{"layout":450,"region":451,"feature":452},"深圳坪山\u002F大鹏","粤港澳大湾区","基因测序仪龙头华大智造、华大基因,测序服务与多组学",{"layout":454,"region":455,"feature":456},"上海张江、苏州工业园、南京","长三角","CRO\u002FCDMO、科研试剂、模式动物、实验设备",{"layout":458,"region":459,"feature":460},"北京亦庄、中关村","京津冀","CGT技术平台、生物信息、模式动物","VERIFIED",1,"2026-10-09T13:20:56.387Z","2026-10-12T14:28:51.476Z",[466,498,531,570,608,634,666,701,733],{"id":467,"chainId":4,"layer":468,"segment":469,"name":469,"keyPoints":470,"companies":471,"sortOrder":480,"isKey":191,"checkState":461,"meta":481,"createdAt":496,"links":497},"cnH_F03_01","上游","基因编辑工具","CRISPR\u002FCas9 碱基编辑 Prime编辑 递送",[472,474,476,478],{"name":377,"note":473},"基因编辑药物研发",{"name":379,"note":475},"新型基因编辑工具开发",{"name":381,"note":477},"碱基编辑技术",{"name":237,"note":479},"基因编辑细胞治疗",0,{"source":60,"experts":482,"policies":485,"chainCode":27,"aggregationZones":487},[483,484],{"org":75,"raw":76,"name":77,"note":78,"title":79},{"org":81,"raw":82,"name":83,"note":84,"title":79},[486],{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},[488,490,492,494],{"city":104,"name":105,"note":489,"level":106},"基因编辑药物研发集聚，博雅辑因RNA碱基编辑",{"city":108,"name":109,"note":491,"level":110},"正序生物等碱基编辑工具与底层技术企业",{"city":112,"name":113,"note":493,"level":96},"（济南 · 国家级）：舜丰生物植物基因编辑工具研发与产业化",{"city":115,"name":116,"note":495,"level":96},"（波士顿 · 海外）：Broad研究所等CRISPR基因编辑技术策源集群","2026-10-12T14:28:51.486Z",[],{"id":499,"chainId":4,"layer":500,"segment":501,"name":501,"keyPoints":502,"companies":503,"sortOrder":462,"isKey":191,"checkState":461,"meta":513,"createdAt":529,"links":530},"cnH_F03_02","中游","载体与递送系统","AAV\u002FLNP病毒载体 外泌体 非病毒递送",[504,506,509,511],{"name":214,"note":505},"基因治疗载体CDMO",{"name":507,"note":508},"金斯瑞蓬勃生物","质粒与病毒载体CDMO",{"name":211,"note":510},"AAV载体规模化生产",{"name":220,"note":512},"AAV\u002F慢病毒载体CDMO",{"source":60,"experts":514,"policies":516,"chainCode":27,"aggregationZones":518},[515],{"org":92,"raw":199,"name":94,"note":200,"title":73},[517],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},[519,521,523,525,527],{"city":108,"name":109,"note":520,"level":110},"和元生物等病毒载体CDMO集聚",{"city":118,"name":119,"note":522,"level":96},"（苏州 · 国家级）：博腾生物质粒与病毒载体CDMO平台",{"city":121,"name":122,"note":524,"level":96},"（广州 · 国家级）：派真生物AAV载体cGMP生产基地",{"city":124,"name":125,"note":526,"level":96},"（武汉 · 国家级）：劲帆医药腺病毒载体等中试平台",{"city":127,"name":128,"note":528,"level":96},"（深圳 · 国家级）：华南细胞工厂逆病毒载体生产线","2026-10-12T14:28:51.492Z",[],{"id":532,"chainId":4,"layer":500,"segment":533,"name":533,"keyPoints":534,"companies":535,"sortOrder":553,"isKey":191,"checkState":461,"meta":554,"createdAt":568,"links":569},"cnH_F03_03","CAR-T\u002FNK细胞治疗","CAR-T CAR-NK TIL 通用型细胞治疗",[536,539,542,545,548,550],{"name":537,"note":538},"药明巨诺","瑞基奥仑赛",{"name":540,"note":541},"复星凯特","阿基仑赛注射液",{"name":543,"note":544},"传奇生物","西达基奥仑赛",{"name":546,"note":547},"驯鹿生物","伊基奥仑赛",{"name":242,"note":549},"纳基奥仑赛",{"name":551,"note":552},"科济药业","实体瘤CAR-T",2,{"source":60,"experts":555,"policies":556,"chainCode":27,"aggregationZones":559},[],[557,558],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},{"raw":229,"date":230,"name":231,"doc_no":96,"issuer":232,"summary":233},[560,562,564,566],{"city":108,"name":109,"note":561,"level":110},"复星凯特、药明巨诺CAR-T上市产品生产",{"city":130,"name":131,"note":563,"level":96},"（南京 · 国家级）：驯鹿生物CAR-T全流程自主生产",{"city":133,"name":134,"note":565,"level":106},"合源生物CAR-T生产基地，集聚60余家企业",{"city":127,"name":128,"note":567,"level":96},"（深圳 · 国家级）：复星凯瑞、普瑞金等细胞治疗企业集聚","2026-10-12T14:28:51.497Z",[],{"id":571,"chainId":4,"layer":500,"segment":572,"name":572,"keyPoints":573,"companies":574,"sortOrder":587,"isKey":191,"checkState":461,"meta":588,"createdAt":606,"links":607},"cnH_F03_04","基因治疗药物","单基因遗传病 罕见病 眼科基因治疗",[575,578,581,584],{"name":576,"note":577},"信念医药","血友病B基因治疗药物",{"name":579,"note":580},"纽福斯","眼科基因治疗药物",{"name":582,"note":583},"天泽云泰","AAV基因治疗药物",{"name":585,"note":586},"本导基因","基因治疗药物开发",3,{"source":60,"experts":589,"policies":592,"chainCode":27,"aggregationZones":595},[590,591],{"org":92,"raw":93,"name":94,"note":95,"title":73},{"org":69,"raw":369,"name":71,"note":370,"title":73},[593,594],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},{"raw":229,"date":230,"name":231,"doc_no":96,"issuer":232,"summary":233},[596,598,600,602,604],{"city":124,"name":125,"note":597,"level":96},"（武汉 · 国家级）：纽福斯眼科基因治疗、滨会生物溶瘤病毒",{"city":108,"name":109,"note":599,"level":110},"基因治疗企业超30家，覆盖AAV与基因编辑",{"city":136,"name":137,"note":601,"level":96},"（上海 · 市级）：细胞免疫治疗、基因治疗项目集聚区",{"city":104,"name":105,"note":603,"level":106},"基因治疗药物研发与成果转化",{"city":118,"name":119,"note":605,"level":96},"（苏州 · 国家级）：基因治疗企业与CGT CDMO集聚","2026-10-12T14:28:51.501Z",[],{"id":609,"chainId":4,"layer":500,"segment":266,"name":266,"keyPoints":610,"companies":611,"sortOrder":37,"isKey":191,"checkState":461,"meta":619,"createdAt":632,"links":633},"cnH_F03_05","mRNA肿瘤疫苗 蛋白替代 mRNA疫苗",[612,614,616,617],{"name":259,"note":613},"mRNA药物研发",{"name":261,"note":615},"mRNA疫苗与药物",{"name":217,"note":218},{"name":265,"note":618},"mRNA药物与疫苗",{"source":60,"experts":620,"policies":621,"chainCode":27,"aggregationZones":623},[],[622],{"raw":203,"date":204,"name":205,"doc_no":96,"issuer":206,"summary":207},[624,626,628,630],{"city":118,"name":119,"note":625,"level":96},"（苏州 · 国家级）：艾博生物等mRNA药物与疫苗研发企业",{"city":108,"name":109,"note":627,"level":110},"斯微生物等mRNA疫苗与药物企业",{"city":139,"name":140,"note":629,"level":106},"威斯津生物mRNA药物与纳米佐剂生产车间",{"city":115,"name":116,"note":631,"level":96},"（波士顿 · 海外）：Moderna等mRNA龙头总部与研发集群","2026-10-12T14:28:51.504Z",[],{"id":635,"chainId":4,"layer":636,"segment":637,"name":637,"keyPoints":638,"companies":639,"sortOrder":649,"isKey":650,"checkState":461,"meta":651,"createdAt":664,"links":665},"cnH_F03_06","下游","临床与商业化","GMP生产 临床注册 支付体系",[640,643,646],{"name":641,"note":642},"药明康德","临床研究与生产服务",{"name":644,"note":645},"泰格医药","临床CRO",{"name":647,"note":648},"昭衍新药","临床前安全性评价",5,false,{"source":60,"experts":652,"policies":653,"chainCode":27,"aggregationZones":655},[],[654],{"raw":229,"date":230,"name":231,"doc_no":96,"issuer":232,"summary":233},[656,658,660,662],{"city":142,"name":143,"note":657,"level":96},"（泰州 · 国家级）：疫苗与生物药临床样品生产、CXO服务",{"city":145,"name":146,"note":659,"level":96},"（北京 · 国家级）：昭衍新药临床前安全性评价总部基地",{"city":118,"name":119,"note":661,"level":96},"（苏州 · 国家级）：CRO\u002FCDMO集群支撑临床与商业化生产",{"city":148,"name":149,"note":663,"level":96},"（上海 · 国家级）：药明康德等临床研究与生产服务平台","2026-10-12T14:28:51.508Z",[],{"id":667,"chainId":4,"layer":468,"segment":668,"name":668,"keyPoints":669,"companies":670,"sortOrder":683,"isKey":650,"checkState":461,"meta":684,"createdAt":699,"links":700},"cnH_F03_07","科研仪器\u002F生物试剂\u002F模式生物","基因测序仪、重组蛋白\u002F抗体\u002F酶试剂、细胞培养基、基因修饰模式动物等上游工具",[671,674,677,680],{"name":672,"note":673},"药康生物","基因编辑小鼠模型",{"name":675,"note":676},"南模生物","基因修饰动物模型",{"name":678,"note":679},"百奥赛图","模式动物与抗体开发",{"name":681,"note":682},"赛业生物","模式动物与科研试剂",6,{"source":60,"experts":685,"policies":686,"chainCode":27,"aggregationZones":688},[],[687],{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},[689,691,693,695,697],{"city":145,"name":146,"note":690,"level":96},"（北京 · 国家级）：义翘神州、百普赛斯重组蛋白与抗体试剂",{"city":151,"name":152,"note":692,"level":110},"赛业生物模式动物、昭衍与中美冠科CRO",{"city":130,"name":131,"note":694,"level":96},"（南京 · 国家级）：药康生物基因编辑小鼠模型",{"city":154,"name":155,"note":696,"level":106},"国仪量子电子显微镜等高端科学仪器",{"city":108,"name":157,"note":698,"level":106},"南模生物基因修饰动物模型等企业集聚","2026-10-12T14:28:51.511Z",[],{"id":702,"chainId":4,"layer":500,"segment":703,"name":703,"keyPoints":704,"companies":705,"sortOrder":715,"isKey":650,"checkState":461,"meta":716,"createdAt":731,"links":732},"cnH_F03_08","基因测序\u002F细胞基因治疗平台\u002FCRO工具","基因测序与合成服务、细胞与基因治疗技术平台、分子诊断、CRO\u002FCDMO工具",[706,708,711,714],{"name":281,"note":707},"基因测序仪",{"name":709,"note":710},"诺禾致源","测序服务与CRO",{"name":712,"note":713},"贝瑞基因","临床基因测序",{"name":284,"note":285},7,{"source":60,"experts":717,"policies":718,"chainCode":27,"aggregationZones":720},[],[719],{"raw":251,"date":252,"name":253,"doc_no":96,"issuer":254,"summary":255},[721,723,725,727,729],{"city":159,"name":160,"note":722,"level":96},"（深圳 · 市级）：华大基因总部，医学检测与基因科技服务",{"city":130,"name":131,"note":724,"level":96},"（南京 · 国家级）：世和基因、真迈生物测序仪与NGS检测",{"city":162,"name":163,"note":726,"level":106},"燃石医学、基准医疗NGS肿瘤检测",{"city":139,"name":165,"note":728,"level":106},"齐碳科技纳米孔基因测序仪",{"city":108,"name":109,"note":730,"level":110},"基因检测与医学检验中心30余家","2026-10-12T14:28:51.514Z",[],{"id":734,"chainId":4,"layer":636,"segment":735,"name":735,"keyPoints":736,"companies":737,"sortOrder":750,"isKey":650,"checkState":461,"meta":751,"createdAt":768,"links":769},"cnH_F03_09","医疗\u002F农业\u002F环保应用","生命科学工具在临床诊断、农业育种、食品环保等领域的应用",[738,741,744,747],{"name":739,"note":740},"华大基因","医学检测与基因科技服务",{"name":742,"note":743},"舜丰生物","基因编辑作物育种",{"name":745,"note":746},"齐禾生科","基因编辑育种",{"name":748,"note":749},"隆平生物","生物育种",8,{"source":60,"experts":752,"policies":755,"chainCode":27,"aggregationZones":757},[753,754],{"org":63,"raw":64,"name":65,"note":66,"title":67},{"org":81,"raw":82,"name":83,"note":84,"title":79},[756],{"raw":273,"date":274,"name":275,"doc_no":96,"issuer":276,"summary":277},[758,760,762,764,766],{"city":167,"name":168,"note":759,"level":96},"（三亚 · 省级）：隆平生物、齐禾生科等生物育种企业集聚",{"city":170,"name":171,"note":761,"level":106},"舜丰生物基因编辑作物产业化基地",{"city":124,"name":125,"note":763,"level":96},"（武汉 · 国家级）：科前生物动物疫苗、禾元生物水稻源白蛋白",{"city":173,"name":174,"note":765,"level":106},"生物法水处理等环保技术装备集群",{"city":159,"name":160,"note":767,"level":96},"（深圳 · 市级）：医学检测与公共卫生基因科技应用","2026-10-12T14:28:51.518Z",[],{"chainId":4,"chainName":5,"matchedTagNames":771,"experts":772,"achievements":774,"topUniversities":776,"note":777},[],{"count":480,"items":773},[],{"count":480,"items":775},[],[],"无标签映射",{"hasMapping":650,"chainId":4,"segments":779},[],[781,783,785,787,789,791],{"name":65,"id":782},"d1013e_c34a932fab8b013d",{"name":71,"id":784},"cmv7rhp1s006shiky6yoo9714",{"name":77,"id":786},"ftxe_11f06e13402998c7",{"name":83,"id":788},"ftxe_719e9633d1f994cc",{"name":88,"id":790},"cmv7rhpow00rchiky19lfbn38",{"name":94,"id":792},"cmv7rhpp200rhhikyhikvxk9l"]